Orion Biotech Opportunities Corp. – NASDAQ:ORIA

Financial Health
0
1
2
3
4
5
6
7
8
9

Orion Biotech Opportunities Corp. stock price quarterly change

+0.99%
quarter

Orion Biotech Opportunities Corp. stock price yearly change

+4.39%
year

Orion Biotech Opportunities Corp. key metrics

Market Cap
 N/A
Enterprise value
 N/A
P/E
 29.26
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 -26.28
PEG ratio
 0.03
EPS
 196178.73
Revenue
 N/A
EBITDA
 -10.55M
Income
 4.90T
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Orion Biotech Opportunities Corp. stock price history

Orion Biotech Opportunities Corp. stock forecast

Orion Biotech Opportunities Corp. financial statements

Profit Margin

Orion Biotech Opportunities Corp. (NASDAQ:ORIA): Profit margin
Mar 2022 0 4.90T
Jun 2022 0 4.06M
Sep 2022 0 2.04M
Dec 2022 0 9.81M
ORIA income statement history

Debt to Assets

Orion Biotech Opportunities Corp. (NASDAQ:ORIA): Debt to assets
Mar 2022 201124000 10.26M 5.1%
Jun 2022 201119800 8.32M 4.14%
Sep 2022 201834778 8.12M 4.02%
Dec 2022 203332786 8.33M 4.1%
ORIA balance sheet history

Cash Flow

Orion Biotech Opportunities Corp. (NASDAQ:ORIA): Cash Flow
Mar 2022 -136.57K 0 0
Jun 2022 -157.35K 0 0
Sep 2022 -77.51K 0 0
Dec 2022 -5.31K 0 -70K
ORIA cash flow history

Orion Biotech Opportunities Corp. other data

Orion Biotech Opportunities Corp.
Hedge Funds Holdings Q1 2023

17.95% -57.13%
of ORIA is owned by hedge funds
19 -33
hedge funds hold ORIA stock
3.59M -11.42M
shares is hold by hedge funds
ORIA hedge funds holdings changes

Frequently Asked Questions (FAQ)

  • When is Orion Biotech Opportunities Corp.'s next earnings date?

    Unfortunately, Orion Biotech Opportunities Corp.'s (ORIA) next earnings date is currently unknown.

  • Does Orion Biotech Opportunities Corp. pay dividends?

    No, Orion Biotech Opportunities Corp. does not pay dividends.

  • What is Orion Biotech Opportunities Corp.'s stock symbol?

    Orion Biotech Opportunities Corp. is traded on the NASDAQ under the ticker symbol "ORIA".

  • What is Orion Biotech Opportunities Corp.'s primary industry?

    Company operates in the Financial Services sector and Shell Companies industry.

  • How do i buy shares of Orion Biotech Opportunities Corp.?

    Shares of Orion Biotech Opportunities Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When Orion Biotech Opportunities Corp. went public?

    Orion Biotech Opportunities Corp. is publicly traded company for more then 4 years since IPO on 2 Jul 2021.

  • What is Orion Biotech Opportunities Corp.'s official website?

    The official website for Orion Biotech Opportunities Corp. is orionbiotechopportunities.com.

  • Where are Orion Biotech Opportunities Corp.'s headquarters?

    Orion Biotech Opportunities Corp. is headquartered at 645 Fifth Avenue, New York, NY.

  • How can i contact Orion Biotech Opportunities Corp.?

    Orion Biotech Opportunities Corp.'s mailing address is 645 Fifth Avenue, New York, NY and company can be reached via phone at +213 3031650.

Orion Biotech Opportunities Corp. company profile:

Orion Biotech Opportunities Corp.

orionbiotechopportunities.com
Exchange:

NASDAQ

Full time employees:

0

Industry:

Shell Companies

Sector:

Financial Services

Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.

+213 3031650
645 Fifth Avenue
New York, NY 10022

CIK: 0001847416
ISIN: KYG6780C1096
CUSIP: G6780C109